UPDATE: RBC Capital Downgrades Dicerna Pharmaceuticals (DRNA) to Sector Perform
Tweet Send to a Friend
(Updated - November 19, 2021 4:30 AM EST)
RBC Capital analyst Luca Issi downgraded Dicerna Pharmaceuticals (NASDAQ: DRNA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Luca Issi downgraded Dicerna Pharmaceuticals (NASDAQ: DRNA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
